- Investing Ideas
- Canadian Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Canadian Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Results
4
0 new
Value score of at least 4 focused on companies with a low market cap.
4 companies
Decibel Cannabis
Market Cap: CA$60.6m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.12
7D
0%
1Y
64.3%
Rubicon Organics
Market Cap: CA$31.8m
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.
ROMJ
CA$0.46
7D
5.7%
1Y
12.2%
SOL Global Investments
Market Cap: CA$1.1m
A private equity firm specializing in emerging growth.
SOL
CA$0.04
7D
0%
1Y
-94.7%
Avant Brands
Market Cap: CA$9.8m
Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.
AVNT
CA$0.64
7D
6.7%
1Y
-16.9%